This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2010 Aug;5(4):359-60.

doi: 10.1007/s11739-010-0357-x. Epub 2010 Feb 23.

Treatment with argatroban in one haemodialysed patient with a heparin-induced thrombocytopenia and thrombotic complications

Adriano Alatri, Marina Foramitti, Oriana Paoletti, Anke Zimmermann, Sophie Testa

PMID: 20177820
DOI: 10.1007/s11739-010-0357-x

Case Reports

Treatment with argatroban in one haemodialysed patient with a heparin-induced thrombocytopenia and thrombotic complications

Adriano Alatri et al. Intern Emerg Med. 2010 Aug.

. 2010 Aug;5(4):359-60.

doi: 10.1007/s11739-010-0357-x. Epub 2010 Feb 23.

Authors

Adriano Alatri, Marina Foramitti, Oriana Paoletti, Anke Zimmermann, Sophie Testa

PMID: 20177820
DOI: 10.1007/s11739-010-0357-x

No abstract available

PubMed Disclaimer

Similar articles

Argatroban in short-term percutaneous ventricular assist subsequent to heparin-induced thrombocytopenia.
Webb DP, Warhoover MT, Eagle SS, Greelish JP, Zhao DX, Byrne JG. Webb DP, et al. J Extra Corpor Technol. 2008 Jun;40(2):130-4. J Extra Corpor Technol. 2008. PMID: 18705550 Free PMC article.
A case report of successful transition from argatroban to warfarin using DOAC-stop in heparin induced thrombocytopenia (HIT).
Makhija K, Chapman K, Prasad R. Makhija K, et al. Pathology. 2021 Oct;53(6):800-802. doi: 10.1016/j.pathol.2020.10.018. Epub 2021 Feb 17. Pathology. 2021. PMID: 33610318 No abstract available.
[Argatroban treatment of heparin-induced immune-mediated thrombocytopenia].
Nielsen JD, Heslet L. Nielsen JD, et al. Ugeskr Laeger. 2009 Feb 16;171(8):610-1. Ugeskr Laeger. 2009. PMID: 19284906 Danish.
Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
Hursting MJ, Soffer J. Hursting MJ, et al. Drug Saf. 2009;32(3):203-18. doi: 10.2165/00002018-200932030-00003. Drug Saf. 2009. PMID: 19338378 Review.
[Heparin-induced thrombocytopenia].
Koide M, Matsuo T. Koide M, et al. Ryoikibetsu Shokogun Shirizu. 1998;(21 Pt 2):307-10. Ryoikibetsu Shokogun Shirizu. 1998. PMID: 9833497 Review. Japanese. No abstract available.

See all similar articles

Cited by

Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses.
Morgan RL, Ashoorion V, Cuker A, Begum H, Ross S, Martinez N, Chong BH, Linkins LA, Warkentin TE, Wiercioch W, Nieuwlaat R, Schünemann H, Santesso N. Morgan RL, et al. Blood Adv. 2020 Oct 27;4(20):5184-5193. doi: 10.1182/bloodadvances.2020002963. Blood Adv. 2020. PMID: 33095876 Free PMC article.
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N. Cuker A, et al. Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489. Blood Adv. 2018. PMID: 30482768 Free PMC article.

References

1. Thromb Haemost. 2008 May;99(5):819-29 - PubMed
1. Intern Emerg Med. 2007 Oct;2(3):202-6 - PubMed
1. Am J Kidney Dis. 2009 Aug;54(2):361-74 - PubMed
1. J Thromb Haemost. 2009 Jul;7 Suppl 1:9-12 - PubMed
1. Am J Cardiovasc Drugs. 2009;9(4):261-82 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Medical
- MedlinePlus Health Information